201 related articles for article (PubMed ID: 23469778)
1. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
2. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen.
Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS
J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721
[TBL] [Abstract][Full Text] [Related]
3. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry.
Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS
World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729
[TBL] [Abstract][Full Text] [Related]
5. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS
J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170
[TBL] [Abstract][Full Text] [Related]
6. Achieving the 'bifecta' using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data.
Spiess PE; Given RW; Jones JS
BJU Int; 2012 Jul; 110(2):217-20. PubMed ID: 21992443
[TBL] [Abstract][Full Text] [Related]
7. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
Williams AK; Martínez CH; Lu C; Ng CK; Pautler SE; Chin JL
Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115
[TBL] [Abstract][Full Text] [Related]
8. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
9. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
[TBL] [Abstract][Full Text] [Related]
10. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
11. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.
Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS
Perm J; 2019; 23():. PubMed ID: 31050644
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of prostate specific antigen nadir after salvage cryotherapy.
Greene GF; Pisters LL; Scott SM; Von Eschenbach AC
J Urol; 1998 Jul; 160(1):86-90. PubMed ID: 9628611
[TBL] [Abstract][Full Text] [Related]
13. Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience.
Philippou P; Yap T; Chinegwundoh F
Urol Int; 2012; 88(2):137-44. PubMed ID: 22285952
[TBL] [Abstract][Full Text] [Related]
14. Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy.
Chang X; Liu T; Zhang F; Zhao X; Ji C; Yang R; Gan W; Zhang G; Li X; Guo H
Int Urol Nephrol; 2015 Feb; 47(2):301-5. PubMed ID: 25510358
[TBL] [Abstract][Full Text] [Related]
15. Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: The important predictors of biochemical recurrence.
Chen PY; Chiang PH; Liu YY; Chuang YC; Cheng YT
Int J Urol; 2018 Jun; 25(6):615-620. PubMed ID: 29756298
[TBL] [Abstract][Full Text] [Related]
16. Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.
Tay KJ; Polascik TJ; Elshafei A; Cher ML; Given RW; Mouraviev V; Ross AE; Jones JS
J Endourol; 2016 Jan; 30(1):43-8. PubMed ID: 26414656
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Bartkowiak D; Thamm R; Bottke D; Siegmann A; Böhmer D; Budach V; Wiegel T
Acta Oncol; 2018 Mar; 57(3):362-367. PubMed ID: 28816074
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.
Hsu CC; Hsu H; Pickett B; Crehange G; Hsu IC; Dea R; Weinberg V; Gottschalk AR; Kurhanewicz J; Shinohara K; Roach M
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):370-7. PubMed ID: 22672747
[TBL] [Abstract][Full Text] [Related]
19. PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.
Shah TT; Peters M; Kanthabalan A; McCartan N; Fatola Y; van der Voort van Zyp J; van Vulpen M; Freeman A; Moore CM; Arya M; Emberton M; Ahmed HU
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):311-6. PubMed ID: 27431499
[TBL] [Abstract][Full Text] [Related]
20. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
